首页> 外文会议>Protein Engineering Summit. >Building Robust and Simple Cell-Based Assays for Interleukins and Their Receptors
【24h】

Building Robust and Simple Cell-Based Assays for Interleukins and Their Receptors

机译:为白细胞介素及其受体构建鲁棒和基于细胞的基于细胞的测定

获取原文

摘要

Ligand-induced receptor dimerization is an early functional step in receptor activation, representing the most proximal, functional read-out for Interleukin receptors. It is well understood that specific signaling receptor subunits can heterodimerize with multiple high affinity receptors from the same family leading to complicated signaling cascades that are implicated in auto-immune, inflammatory and oncogenic diseases. Here we present a novel application of our PathHunter? technology to monitor receptor-receptor interactions at the surface of intact live cells, applicable to diverse receptor types, with a specific focus on the interleukin family of receptors. The high specificity, simplicity of the assay protocol, serum tolerance and reproducibility of these assays has enabled their use in cell-based screening, functional characterization and QC lot release assays. Examples from our menu of assays spanning ~80% of all human interleukins will be presented, including assays for Anakinra and Tocilizumab. These robust assays have excellent reproducibility, accuracy and precision, demonstrating their suitability for use as QC Lot Release assays.
机译:配体诱导的受体二聚化是受体活化的早期功能步骤,代表白细胞介素受体的最近似功能读出。众所周知,特定的信号受体亚基可以与来自同一家族的多个高亲和力受体的异二种化,导致复杂的信号传导级联,其​​涉及自身免疫,炎症和致癌疾病。在这里,我们提出了一种新的我们的途径应用程序?用于监测完整活细胞表面的受体受体相互作用的技术,适用于不同的受体类型,具有特异性关注白细胞介素家族的受体。这些测定的测定方案的高特异性,简单性,这些测定的血清耐受性和再现性使其在基于细胞的筛选,功能性表征和QC批次释放测定中使用。从跨越〜80%的所有人白细胞介素的测定菜单中的实例将被呈现,包括对Anakinra和ToColizumab的测定。这些稳健的测定具有出色的再现性,准确性和精度,证明了它们使用的适用性作为QC批次释放测定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号